FOMEPIZOLE FOR INJECTION 1 G
FOMEPIZOLE : 1 G · DIN 02435667 · STERIMAX INC
Health Canada status: MARKETED
What is FOMEPIZOLE FOR INJECTION?
FOMEPIZOLE FOR INJECTION 1 G contains FOMEPIZOLE : 1 G. It is listed in the Health Canada Drug Product Database under DIN 02435667, held by STERIMAX INC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 22-Sep-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is FOMEPIZOLE FOR INJECTION used for?
Antidote for ethylene glycol (antifreeze) or methanol (windshield washer fluid) poisoning, or suspected ingestion, alone or with hemodialysis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02435667 |
|---|---|
| Brand name | FOMEPIZOLE FOR INJECTION |
| Generic / active ingredient | FOMEPIZOLE : 1 G |
| Manufacturer | STERIMAX INC |
| Strength | 1 G |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | V03AB34 FOMEPIZOLE |
| AHFS class | 12:02.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 22-Sep-2015 |
| Original market date | 2018-06-12 00:00:00 |
How is it administered?
Loading dose: 15 mg/kg. Maintenance: 10 mg/kg every 12 hours for 4 doses, then 15 mg/kg every 12 hours. Administer as slow IV infusion over 30 minutes. Adjustments required during hemodialysis.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at controlled room temperature (20 to 25°C). Vials are for single use only. Diluted solution stable for 24 hours refrigerated or at room temperature.
How is it supplied?
Dual pack carton containing two 1.5 mL vials; single pack carton containing one 1.5 mL vial.
Contraindications
Documented serious hypersensitivity reaction to fomepizole or other pyrazoles.
Warnings and precautions
Do not give undiluted or by bolus (risk of venous irritation). Monitor for anaphylaxis and minor allergic reactions (rash, eosinophilia). Monitor hepatic enzymes and WBC counts.
What can be used instead?
Other Canadian products sharing ATC code V03AB34 FOMEPIZOLE. 2 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ANTIZOL | 1 G | LIQUID | ENDO OPERATIONS LTD. | MARKETED | DIN 02242980 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.